Brain Hemorrhage – Pipeline Review, H1 2012

Global Markets Direct
March 19, 2012
41 Pages - SKU: GMD3811069
Acromegaly - Pipeline Review, H2 2014
8/31/2014 | published by: Global Markets Direct
Acromegaly - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Acromegaly - Pipeline Review, H2 2014’, provides an overview of the Acromegaly’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Acromegaly, complete with comparative  |  read more...
USD 2,000
Diabetic Neuropathy - Pipeline Review, H2 2014
8/25/2014 | published by: Global Markets Direct
Diabetic Neuropathy - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Diabetic Neuropathy - Pipeline Review, H2 2014’, provides an overview of the Diabetic Neuropathy’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Diabetic  |  read more...
USD 2,000
Typhoid Fever - Pipeline Review, H2 2014
8/25/2014 | published by: Global Markets Direct
Typhoid Fever - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Typhoid Fever - Pipeline Review, H2 2014’, provides an overview of the Typhoid Fever’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Typhoid  |  read more...
USD 2,000
Perennial Allergic Rhinitis - Pipeline Review, H2 2014
8/25/2014 | published by: Global Markets Direct
Perennial Allergic Rhinitis - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Perennial Allergic Rhinitis - Pipeline Review, H2 2014’, provides an overview of the Perennial Allergic Rhinitis’s therapeutic pipeline. This report provides comprehensive information on the therapeutic  |  read more...
USD 2,000
Epilepsy - Pipeline Review, H2 2014
8/31/2014 | published by: Global Markets Direct
Epilepsy - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Epilepsy - Pipeline Review, H2 2014’, provides an overview of the Epilepsy’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Epilepsy, complete with comparative  |  read more...
USD 2,000
Peripheral Neuropathy (Sensory Neuropathy) - Pipeline Review, H2 2014
8/25/2014 | published by: Global Markets Direct
Peripheral Neuropathy (Sensory Neuropathy) - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Peripheral Neuropathy (Sensory Neuropathy) - Pipeline Review, H2 2014’, provides an overview of the Peripheral Neuropathy (Sensory Neuropathy)’s therapeutic pipeline. This report provides comprehensive information  |  read more...
USD 2,000
Heart Valve Disease Global Clinical Trials Review, H2, 2014
9/10/2014 | published by: GlobalData
Heart Valve Disease Global Clinical Trials Review, H2, 2014 Summary GlobalData's clinical trial report, “Heart Valve Disease Global Clinical Trials Review, H2, 2014 provides data on the Heart Valve Disease clinical trial scenario. This report provides elemental  |  read more...
USD 2,500
African Trypanosomiasis - Pipeline Review, H2 2014
8/31/2014 | published by: Global Markets Direct
African Trypanosomiasis - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘African Trypanosomiasis - Pipeline Review, H2 2014’, provides an overview of the African Trypanosomiasis’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for African  |  read more...
USD 2,000
OpportunityAnalyzer: Non-Hodgkin’s B-Cell Lymphoma - Opportunity Analysis and Forecast to 2018
8/25/2014 | published by: GlobalData
OpportunityAnalyzer: Non-Hodgkin’s B-Cell Lymphoma - Opportunity Analysis and Forecast to 2018 Summary The competitive landscape in the B-cell NHL markets in the US, France, Italy, Germany, Spain and the UK is poised to undergo a dramatic shift  |  read more...
USD 7,995
Uveitis - Pipeline Review, H2 2014
8/31/2014 | published by: Global Markets Direct
Uveitis - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Uveitis - Pipeline Review, H2 2014’, provides an overview of the Uveitis’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Uveitis, complete with comparative  |  read more...
USD 2,000
 

SELECT A LICENSE

    Online Download  USD 500  
    Global Site License  USD 1,500  
 
US: 800.298.5699
Int'l: +1.240.747.3093
 

Share this report


    Other tasks

     
     
    Join Alert Me now!
    Receive bi-weekly email alerts on new market research

    Sign up today!